Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?

Mitochondrial abnormalities have been identified as a central mechanism in multiple neurodegenerative diseases and, therefore, the mitochondria have been explored as a therapeutic target. This review will focus on the evidence for mitochondrial abnormalities in the two most common neurodegenerative...

Full description

Saved in:

Bibliographic Details
Published in:	Biochemical Society transactions Vol. 46; no. 4; p. 891
Main Authors:	Macdonald, Ruby, Barnes, Katy, Hastings, Christopher, Mortiboys, Heather
Format:	Journal Article
Language:	English
Published:	England 20.08.2018
Subjects:	Alzheimer Disease - drug therapy Alzheimer Disease - genetics Alzheimer Disease - metabolism Alzheimer Disease - pathology Animals Antioxidants - metabolism Antioxidants - pharmacology Drug Delivery Systems Humans Mitochondria - drug effects Mitochondria - metabolism Mitochondrial Dynamics Mitochondrial Proteins - metabolism Models, Biological Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Parkinson Disease - drug therapy Parkinson Disease - metabolism Parkinson Disease - pathology therapeutics mitochondrial dysfunction Parkinson's disease Alzheimer's disease
ISSN:	1470-8752, 1470-8752
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!